Calcineurin regulates myocardial function during acute endotoxemia.

Area of Science:

• Cardiovascular Physiology
• Mitochondrial Biology
• Sepsis Research

Background:

• Endotoxemia impairs cardiac contractile function, potentially via increased nitric oxide (NO) and mitochondrial dysfunction.
• Cyclosporin A (CsA) is known to preserve cardiac function, possibly by reducing NO and inhibiting mitochondrial permeability transition (MPT).
• The precise mechanisms by which CsA protects the heart during endotoxemia remain unclear.

Purpose of the Study:

• To investigate if CsA protects against endotoxin-induced cardiac dysfunction.
• To determine if CsA attenuates NO production and preserves mitochondrial function during endotoxemia.
• To explore the role of calcineurin in regulating cardiac function and mitochondrial integrity during sepsis.

Main Methods:

• Left ventricular function was assessed in cats over 4 hours following LPS administration.
• Animals were pretreated with CsA or tacrolimus (FK506), a calcineurin inhibitor without MPT activity.
• Myocardial tissue was analyzed for NO synthase-2, nitration, carbonylation, and mitochondrial parameters.

Main Results:

• LPS induced cardiac dysfunction, altered mitochondrial function, and increased protein nitration.
• CsA and FK506 pretreatment normalized cardiac performance, mitochondrial respiration, and reduced protein nitration.
• Both CsA and FK506 increased myocardial protein carbonylation despite enhanced manganese superoxide dismutase activity.

Conclusions:

• Calcineurin plays a critical role in regulating cardiac mitochondrial respiration during acute endotoxemia.
• Calcineurin inhibition impacts tissue nitration and protein carbonylation in the heart during sepsis.
• These findings highlight calcineurin as a key mediator of cardiac contractile function in endotoxemia.